The Asia Pacific biosurgical agent market was negatively impacted by the COVID-19 pandemic. However, the overall market for biosurgical agent will exhibit modest growth over the forecast period…
The Asia Pacific heart valve device market will continue to experience robust growth after recovering from the impact of COVID-19. The market will be primarily driven by rapid adoption of THV…
The Asia Pacific large-joint reconstructive implant market was limited by the COVID-19 pandemic given that many hip and knee implant procedures are considered elective; however, the market…
The Asia Pacific interventional oncology device market will see strong growth through 2032 driven by a large and rapidly expanding patient population, increasing popularity of minimally invasive…
The Asia Pacific large-joint reconstructive implant market was limited by the COVID-19 pandemic given that many hip and knee implant procedures are considered elective; however, the market…
The Asia Pacific ENT device market saw a severe short-term impact from the COVID-19 pandemic in 2020 as many ENT procedures were delayed or canceled. Although the market rebounded in 2021 and 2022…
The Asia Pacific biosurgical agent market was negatively impacted by the COVID-19 pandemic. However, the overall market for biosurgical agent will exhibit modest growth over the forecast period…
COVID-19 pandemic has negatively impacted the Asia Pacific transcatheter embolization and occlusion device market, but the impact of COVID-19 is limited and short term, the market will expand at a…
Despite the short term challenges posed by the COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth through 2031 driven by a large and rapidly expanding…
Although the global COVID-19 pandemic negatively impacted the Asia Pacific EP mapping and ablation device market in 2020, the market has shown strong recovery and will resume prepandemic growth…
The COVID-19 pandemic impacted the Asia Pacific spinal implant market in the short term, slowing growth due to deferral of elective procedures accompanied by supply chain issues and pricing…
The Asia Pacific heart valve device market has seen a moderately negative impact due to the global COVID-19 pandemic. However, in the long term, the market will be driven by positive results from…
The Asia Pacific laparoscopic device market was negatively impacted by the COVID-19 pandemic, resulting in declines in procedure volumes, units sold, and overall market value in 2020. However, the…
The global COVID-19 pandemic negatively impacted the Asia Pacific structural heart closure device market to some extent. Given most structural heart closure procedures, including congenital heart…
The Asia Pacific dialysis access treatment device market will grow modestly through 2031, driven by the expanding ESRD population, rising uptake of newer products—such as DCBs—along with…